The announcement of a class action lawsuit against Regeneron Pharmaceuticals is likely to have a negative short-term impact on its stock price. Legal issues can create uncertainty and potential financial liabilities, which may concern investors. The high relevance and importance scores reflect the direct mention of the lawsuit and its potential implications for the company's financial health.